The Food and Drug Administration (FDA) is offering a funding opportunity for expanding education on skin lightening products. This grant aims to advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners to raise awareness about potential risks from skin lightening products containing hydroquinone and/or mercury. The funding opportunity seeks innovative and community-based strategies and activities to strengthen the science base for education and public health awareness on the use of over-the-counter (OTC) skin lightening products. The grant amount is set at $250,000, with no cost sharing or matching requirement. The opportunity is forecasted for the fiscal year 2024 and is open to unrestricted applicants. For more information, interested parties can contact Terrin Brown, the grantor, at terrin.brown@fda.hhs.gov or 240-402-7610.